Vitexin mitigates AIM2 inflammasome-mediated mitochondrial dysfunction and neuroinflammation in chronic constriction injury induced neuropathy model
International Immunopharmacology · 2025-06 · 158 · 114877
DOI: 10.1016/j.intimp.2025.114877 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-06. Verfasst von Anubroto Pal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Kolkata 700054, India. Hauptthemen laut MEDLINE: Apigenin, Mitochondria, Inflammasomes, Neuralgia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Kolkata 700054, India.
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Kolkata 700054, India.
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, SAS Nagar, Punjab 160062, India.
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Kolkata 700054, India. Electronic address: sbanerjee@niperkolkata.ac.in.
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, SAS Nagar, Punjab 160062, India. Electronic address: ashutosh@niper.ac.in.
Förderung
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
Zitieren
APA
Pal, A., Sharan, L., Das, A., Paul, S., Babu, S. S., Das, S., Banerjee, S., & Kumar, A. (2025). Vitexin mitigates AIM2 inflammasome-mediated mitochondrial dysfunction and neuroinflammation in chronic constriction injury induced neuropathy model. International Immunopharmacology, 158, 114877. https://doi.org/10.1016/j.intimp.2025.114877
Vancouver
Pal A, Sharan L, Das A, Paul S, Babu SS, Das S, et al. Vitexin mitigates AIM2 inflammasome-mediated mitochondrial dysfunction and neuroinflammation in chronic constriction injury induced neuropathy model. International Immunopharmacology. 2025;158:114877. doi:10.1016/j.intimp.2025.114877
BibTeX
@article{Pal2025,
author = {Pal, Anubroto and Sharan, Lokesh and Das, Arka and Paul, Shuchismita and Babu, S Sarath and Das, Sourav and Banerjee, Sugato and Kumar, Ashutosh},
title = {Vitexin mitigates AIM2 inflammasome-mediated mitochondrial dysfunction and neuroinflammation in chronic constriction injury induced neuropathy model},
journal = {International Immunopharmacology},
year = {2025},
volume = {158},
pages = {114877},
doi = {10.1016/j.intimp.2025.114877}
}
EUVIMED